ChemicalBook >> CAS DataBase List >>Glumetinib
Glumetinib
- CAS No.
- 1642581-63-2
- Chemical Name:
- Glumetinib
- Synonyms
- SCC244;Glumetinib;Gumarontinib;GLUMETINIB (SCC244);Fenbuconazole Impurity 1;6-(1-Methyl-1H-pyrazol-4-yl)-1-((6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)sulfonyl)-1H-pyrazolo[4,3-b]pyridine;1H-Pyrazolo[4,3-b]pyridine, 6-(1-methyl-1H-pyrazol-4-yl)-1-[[6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]sulfonyl]-;SCC 244,proliferation,tumor,cancer,Glumetinib,bioavailable,oral,HCC,SCC-244,inhibit,c-Met/HGFR,ATP-competitive,cell,NSCLC,Inhibitor
- CBNumber:
- CB64667942
- Molecular Formula:
- C21H17N9O2S
- Molecular Weight:
- 459.48
- MDL Number:
- MFCD31693844
- MOL File:
- 1642581-63-2.mol
Last updated:2023-06-08 09:03:00
| Density | 1.61±0.1 g/cm3(Predicted) |
|---|---|
| storage temp. | -20°C |
| solubility | Soluble in DMSO (>25 mg/ml) |
| form | solid |
| pka | 0.09±0.10(Predicted) |
| color | Beige |
| Stability | Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month. |
| FDA UNII | 7JTT036WGX |
| NCI Drug Dictionary | glumetinib |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319-H335 | |||||||||
| Precautionary statements | P261-P305+P351+P338 | |||||||||
| NFPA 704 |
|
Glumetinib price More Price(12)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 28952 | Glumetinib | 1642581-63-2 | 1mg | $36 | 2024-03-01 | Buy |
| Cayman Chemical | 28952 | Glumetinib | 1642581-63-2 | 25mg | $638 | 2024-03-01 | Buy |
| Cayman Chemical | 28952 | Glumetinib | 1642581-63-2 | 5mg | $155 | 2024-03-01 | Buy |
| Cayman Chemical | 28952 | Glumetinib | 1642581-63-2 | 10mg | $290 | 2024-03-01 | Buy |
| AK Scientific | 1891EF | Glumetinib | 1642581-63-2 | 10mg | $421 | 2021-12-16 | Buy |
Glumetinib Chemical Properties,Uses,Production
Description
Glumetinib (1642581-63-2) is a highly selective (2400-fold selectivity against a panel of 312 kinases) and potent (IC50 = 0.42 nM) inhibitor of c-Met kinase.? It induced tumor regression in MET-driven CDX (MKN-45, SNU-5, EBC-1) and PDX (4 NSCLC, 5 HCC) tumor models.
References
Ai et al. (2018), Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models; Cancer Res., 17 751
Glumetinib Preparation Products And Raw materials
Raw materials
Preparation Products
Glumetinib Suppliers
Global( 45)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32715 | 60 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6313 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10523 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
| Aladdin Scientific | +1-+1(833)-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 |
| Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 | orders@jknbiochem.com | China | 4691 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131980 | 58 |
| Dalian Meilun Biotech Co., Ltd. | 0411-62910999 13889544652 | sales@meilune.com | China | 4663 | 58 |
| ShangHai Caerulum Pharma Discovery Co., Ltd. | 18149758185 | sales-cpd@caerulumpharma.com | China | 3427 | 58 |
1642581-63-2(Glumetinib)Related Search:
Glumetinib
GLUMETINIB (SCC244)
SCC244
1H-Pyrazolo[4,3-b]pyridine, 6-(1-methyl-1H-pyrazol-4-yl)-1-[[6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]sulfonyl]-
Gumarontinib
6-(1-Methyl-1H-pyrazol-4-yl)-1-((6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)sulfonyl)-1H-pyrazolo[4,3-b]pyridine
SCC 244,proliferation,tumor,cancer,Glumetinib,bioavailable,oral,HCC,SCC-244,inhibit,c-Met/HGFR,ATP-competitive,cell,NSCLC,Inhibitor
Fenbuconazole Impurity 1
1642581-63-2
C21H17N9O2S